In this episode of Biotalk, Josh Hamermesh, VP of Locust Walk interviewed his long lasting friend and colleague, Fred Chereau, CEO of LogicBio. They discussed industry trends on gene therapy and LogicBio recent

Episode 4: Stuart Kliman, Vantage Partners

Jul 13th, 2017 34m 46s

In this Episode of Biotalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Stuart Kliman ([email protected]), Founder and Partner at Vantage Partners, a global management consulting firm that specializes in the areas of negoti

Episode 3: Roger Longman, Real Endpoints

Apr 18th, 2017 36m 25s

In this episode of BioTalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Roger Longman, CEO of Real Endpoints, about the pricing and reimbursement issues that are affecting the biopharmaceutical industry, with a particular focus on th

Episode 2: Bradley Campbell, Amicus Therapeutics

Mar 23rd, 2017 33m 15s

In this episode of Biotalk podcast, Josh Hamermesh, Vice President of Locust Walk interviews Bradley Campbell, President& COO of Amicus Therapeutics. Amicus is very much at the forefront developing and commercializing important therapies to tre

Episode 1: Chris Ehrlich, Locust Walk

Feb 6th, 2017 20m 26s

Biotalk is a deal maker’s playbook to making an impact and generating returns in life sciences. Our guest speakers are industry leaders and institutional and family office investors who share their experience and views on deal making and indus

Rate